Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 14, 2021, after the close
10-Q filed May 14, 2021, 44 days after period end · 0001171843-21-003532
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | — | $6.02K | $2.50K | $2.50K |
| Net Income | -$4.03M | -$2.38M | -$3.11M | -$2.15M |
| EPS Diluted | -$0.79 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$5.58 |
| -$3.42 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
